Entourage Health Corp. (ETRGF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Entourage Health Corp. (ETRGF) with AI Score 35/100 (Weak). Entourage Health Corp. is a Canadian cannabis company focused on the production and distribution of cannabis products for both medical and adult-use markets. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 17, 2026Entourage Health Corp. (ETRGF) Healthcare & Pipeline Overview
Entourage Health Corp. is a Canadian cannabis producer serving the medical and adult-use markets, offering a range of cannabis products under brands like Color Cannabis and Saturday Cannabis. Facing a competitive landscape and evolving regulatory environment, Entourage focuses on product innovation and market expansion within Canada's cannabis sector.
Investment Thesis
Entourage Health Corp. faces a challenging market environment with a negative profit margin of -113.4% and a low gross margin of 9.1%. The company's high beta of 1.81 suggests significant volatility relative to the market. Growth catalysts include potential expansion of its product lines and increased market penetration within Canada. However, investors should be aware of the risks associated with operating in a highly regulated and competitive industry. The company's ability to improve its financial performance and capitalize on growth opportunities will be critical to its long-term success.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $0.00B indicates a small-cap company with potential for growth but also higher risk.
- P/E ratio of -0.03 suggests the company is not currently profitable.
- Profit Margin of -113.4% highlights significant challenges in achieving profitability.
- Gross Margin of 9.1% indicates a low margin on sales after accounting for the cost of goods sold.
- Beta of 1.81 suggests the stock is more volatile than the overall market.
Competitors & Peers
Strengths
- Established brands in the Canadian cannabis market.
- Diverse product portfolio catering to various consumer segments.
- Expertise in cannabis cultivation and processing.
- Strategic partnerships with retailers and distributors.
Weaknesses
- Negative profit margin and low gross margin.
- High beta indicating significant stock volatility.
- Limited geographic reach primarily focused on Canada.
- Dependence on regulatory approvals and compliance.
Catalysts
- Upcoming: Potential regulatory changes in Canada that could expand the cannabis market.
- Ongoing: Expansion of product offerings to include new cannabis-infused products.
- Ongoing: Increased market penetration through strategic partnerships and distribution agreements.
Risks
- Potential: Intense competition from other cannabis producers.
- Ongoing: Evolving regulations and compliance requirements.
- Ongoing: Price pressures and margin erosion.
- Potential: Changing consumer preferences and market trends.
- Ongoing: Limited access to capital and financing options.
Growth Opportunities
- Expansion of Product Lines: Entourage Health Corp. can expand its product lines to include new and innovative cannabis products, such as infused beverages, concentrates, and wellness products. The market for cannabis-infused products is growing, offering opportunities to cater to diverse consumer preferences. The timeline for product development and launch is approximately 6-12 months, with a potential market size of $500 million annually.
- Increased Market Penetration in Canada: Entourage can increase its market penetration by expanding its distribution network and retail presence across Canada. This includes establishing partnerships with retailers, opening new dispensaries, and leveraging e-commerce platforms. The Canadian cannabis market is projected to reach $5 billion by 2027, offering significant growth opportunities.
- Strategic Partnerships and Acquisitions: Entourage can pursue strategic partnerships and acquisitions to expand its capabilities, market reach, and product portfolio. This includes partnering with other cannabis companies, technology providers, or research institutions. Strategic alliances can provide access to new markets, technologies, and expertise, accelerating growth and innovation.
- Focus on Medical Cannabis Market: Entourage can focus on expanding its presence in the medical cannabis market by developing specialized products and services for patients with specific medical conditions. This includes conducting clinical research, collaborating with healthcare professionals, and providing educational resources for patients. The medical cannabis market offers opportunities for higher margins and long-term customer relationships.
- Development of Proprietary Cannabis Strains: Entourage can invest in the development of proprietary cannabis strains with unique characteristics, such as high THC or CBD content, specific terpene profiles, or enhanced therapeutic effects. Proprietary strains can differentiate the company's products and create a competitive advantage in the market. The development process typically takes 12-18 months, with a potential market value of $100 million annually.
Opportunities
- Expansion into new product categories, such as infused beverages and wellness products.
- Increased market penetration in Canada through expanded distribution.
- Strategic partnerships and acquisitions to enhance capabilities.
- Focus on the medical cannabis market with specialized products.
Threats
- Intense competition from other cannabis producers.
- Evolving regulations and compliance requirements.
- Price pressures and margin erosion.
- Changing consumer preferences and market trends.
Competitive Advantages
- Brand recognition through established brands like Color Cannabis and Starseed Medicinals.
- Proprietary cannabis strains and formulations.
- Established distribution network and retail partnerships.
- Expertise in cannabis cultivation, processing, and manufacturing.
About ETRGF
Entourage Health Corp., formerly known as WeedMD Inc., is a Canadian cannabis company that cultivates, processes, and distributes a diverse range of cannabis products. Founded with the vision of providing high-quality cannabis for medical and recreational use, the company has evolved to become a player in the Canadian cannabis market. Entourage offers cannabis plants, dried cannabis, oils, topicals, extracts, and edibles, catering to various consumer preferences and medical needs. The company's products are marketed under several brands, including Color Cannabis, known for its recreational appeal; Saturday Cannabis, targeting a specific consumer segment; Starseed Medicinals, focused on the medical cannabis market; and Mary's Medicinals, offering a range of wellness-focused products. Entourage Health Corp. operates primarily within Canada, focusing on expanding its market share and product offerings in the Canadian cannabis landscape. The company is headquartered in Toronto, Canada, and continues to adapt to the evolving regulatory environment and consumer demands within the cannabis industry.
What They Do
- Cultivates cannabis plants for medical and adult-use markets.
- Processes cannabis into various product formats, including dried cannabis, oils, and extracts.
- Manufactures cannabis-infused products such as edibles and topicals.
- Distributes cannabis products through various channels, including retail stores and online platforms.
- Markets and sells cannabis products under various brand names, including Color Cannabis and Starseed Medicinals.
- Conducts research and development to innovate new cannabis products and formulations.
Business Model
- Cultivation and production of cannabis.
- Processing and manufacturing of cannabis products.
- Distribution and sale of cannabis products through retail and wholesale channels.
- Branding and marketing of cannabis products to consumers.
Industry Context
Entourage Health Corp. operates within the rapidly evolving Canadian cannabis industry. The market is characterized by increasing competition, evolving regulations, and shifting consumer preferences. While the industry offers significant growth potential, companies face challenges related to regulatory compliance, pricing pressures, and brand differentiation. Entourage competes with other licensed producers in Canada, striving to capture market share through product innovation, strategic partnerships, and effective marketing strategies. The industry is also subject to ongoing regulatory changes that can impact production, distribution, and marketing practices.
Key Customers
- Adult-use cannabis consumers seeking recreational products.
- Medical cannabis patients seeking therapeutic relief.
- Retail dispensaries and cannabis stores.
- Wholesale distributors and partners.
Financials
Chart & Info
Entourage Health Corp. (ETRGF) stock price: Price data unavailable
Latest News
No recent news available for ETRGF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ETRGF.
Price Targets
Wall Street price target analysis for ETRGF.
MoonshotScore
What does this score mean?
The MoonshotScore rates ETRGF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: George Scorsis
CEO
George Scorsis is an experienced executive with a background in the beverage and cannabis industries. Prior to joining Entourage Health Corp., he held leadership positions at various companies, including Liberty Health Sciences and Aphria Inc. His experience includes strategic planning, business development, and operational management. Scorsis has a track record of driving growth and innovation in highly regulated industries.
Track Record: Since becoming CEO, George Scorsis has focused on streamlining operations, expanding product offerings, and strengthening the company's market position. Key milestones under his leadership include the rebranding of WeedMD Inc. to Entourage Health Corp. and the launch of new cannabis products. Scorsis has also emphasized strategic partnerships and acquisitions to drive growth and enhance shareholder value.
ETRGF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Entourage Health Corp. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting, regulatory oversight, and investor protection compared to those listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks involves higher risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Higher price volatility due to low trading volume.
- Potential for wider bid-ask spreads and execution challenges.
- Increased risk of fraud or manipulation.
- Limited regulatory oversight and investor protection.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Review the company's risk factors and potential liabilities.
- Consult with a qualified financial advisor.
- Understand the risks associated with OTC investing.
- Established brands in the Canadian cannabis market.
- Operations in a regulated industry (cannabis).
- Experienced management team.
- Publicly traded status, even on the OTC market.
- Presence of a functioning website and investor relations materials.
Common Questions About ETRGF
What does Entourage Health Corp. do?
Entourage Health Corp. is a Canadian cannabis company focused on the production, processing, and distribution of cannabis products for both medical and adult-use markets. The company offers a diverse range of cannabis products, including dried cannabis, oils, topicals, extracts, and edibles, marketed under various brand names such as Color Cannabis, Saturday Cannabis, and Starseed Medicinals. Entourage operates primarily within Canada, focusing on expanding its market share and product offerings in the Canadian cannabis landscape.
What do analysts say about ETRGF stock?
Analyst coverage of Entourage Health Corp. (ETRGF) is limited due to its OTC listing and small market capitalization. Key valuation metrics, such as the P/E ratio of -0.03 and negative profit margin of -113.4%, suggest the company is currently not profitable. Growth considerations include the potential for increased market penetration in Canada and expansion into new product categories. However, investors should be aware of the risks associated with operating in a highly regulated and competitive industry.
What are the main risks for ETRGF?
Entourage Health Corp. faces several risks, including intense competition from other cannabis producers, evolving regulations and compliance requirements, price pressures and margin erosion, and changing consumer preferences and market trends. The company's high beta of 1.81 indicates significant stock volatility. Additionally, as an OTC-listed company, ETRGF is subject to limited financial disclosure and transparency, increasing the risk of fraud or manipulation. Investors should carefully consider these risks before investing in ETRGF.
What are the key factors to evaluate for ETRGF?
Entourage Health Corp. (ETRGF) currently holds an AI score of 35/100, indicating low score. Key strength: Established brands in the Canadian cannabis market.. Primary risk to monitor: Potential: Intense competition from other cannabis producers.. This is not financial advice.
How frequently does ETRGF data refresh on this page?
ETRGF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven ETRGF's recent stock price performance?
Recent price movement in Entourage Health Corp. (ETRGF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established brands in the Canadian cannabis market.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider ETRGF overvalued or undervalued right now?
Determining whether Entourage Health Corp. (ETRGF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying ETRGF?
Before investing in Entourage Health Corp. (ETRGF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on publicly available information and may be subject to limitations.
- OTC market data may be less reliable than data from major exchanges.
- Analyst coverage is limited due to the company's OTC listing and small market capitalization.